Manipal Health Enterprises Ltd
16 Nov 2026 12:00 AM
Manipal Health Enterprises Ltd consolidated sales up 9.99% on year in Q2FY2027, net profit rose by 17.07%,
Manipal Health Enterprises Ltd`s net profit expanded by 17.07% to Rs 284.98 crore, while revenue from operations slightly gained 9.99% to Rs 3399.35 crore in Q2FY27 over Q2FY26.
The market capitalization of Hospital industry group stocks on BSE stood at Rs 6.68 lakh crore, advancing by 14.45%. It has improved by 0.99% over last one week and softened by 4.41% in last one month while the market capitalization of Manipal Health Enterprises Ltd has inched up 2.31% and 6.32% in the same period respectively.
Profit before tax (PBT) of Manipal Health Enterprises Ltd stood at Rs 371.56 crore in Q2 FY27, retreating 11.07% year-on-year, and jumping 17.89% quarter-on-quarter. EBITDA came in at Rs 772 crore, expanding by 23.83% YoY and surging by 16.65% sequentially.
Total expenses posted a minor rise of 7.51% to Rs 2732.23 crore in Q2FY27 over Q2FY26. During the quarter, employee benefits expense was at Rs 486.76 crore, ticking higher by 5.36% YoY.
For FY26, revenue from operations jumped by 25.40% to Rs 10335.75 crore, while net profit dropped 15.26% to Rs 916.59 crore, compared to previous FY. EBITDA surged by 217771% to Rs 2426.47 crore, and PBT dipped slightly 5.17% to Rs 1178.1 crore compared to previous FY.
The company`s consolidated net cash flow from operating activities stood at Rs 2078.4 crore in FY26, as against Rs 1569.83 crore in FY25.
Manipal Health Enterprises Ltd
14 Nov 2026 12:00 AM
Manipal Health Enterprises Ltd consolidated sales up 9.99% on year in Q2FY2027, net profit expanded by 17.07%,
Manipal Health Enterprises Ltd share price inched up 0.48% to Rs 680.0 after the company`s net profit registered a growth of 17.07% to Rs 284.98 crore, while revenue from operations improved marginally 9.99% to Rs 3399.35 crore in Q2FY27 over Q2FY26.
The market capitalization of Hospital industry group stocks on BSE stood at Rs 6.69 lakh crore, heading higher 14.45%. It has improved by 2.14% over last one week and softened by 4.55% in last one month while the market capitalization of Manipal Health Enterprises Ltd has marginally improved by 5.10% and 3.87% in the same period respectively.
Profit before tax (PBT) of Manipal Health Enterprises Ltd stood at Rs 371.56 crore in Q2 FY27, dropping 11.07% year-on-year, and expanding by 17.89% quarter-on-quarter. EBITDA came in at Rs 772 crore, rallying 23.83% YoY and surging by 16.65% sequentially.
Total expenses posted a minor rise of 7.51% to Rs 2732.23 crore in Q2FY27 over Q2FY26. During the quarter, employee benefits expense was at Rs 486.76 crore, inching up 5.36% YoY.
For FY26, revenue from operations witnessed a strong growth of 25.40% to Rs 10335.75 crore, while net profit declined by 15.26% to Rs 916.59 crore, compared to previous FY. EBITDA witnessed a strong improvement of 217771% to Rs 2426.47 crore, and PBT dipped slightly 5.17% to Rs 1178.1 crore compared to previous FY.
The company`s consolidated net cash flow from operating activities stood at Rs 2078.4 crore in FY26, as against Rs 1569.83 crore in FY25.
Manipal Health Enterprises Ltd
07 Oct 2026 12:00 AM
Manipal Health Enterprises confirms securities dematerialization compliance with Indian regulators,
Manipal Health Enterprises Limited submitted a certificate to the National Stock Exchange of India Limited and BSE Limited, received from KFin Technologies Limited, regarding the dematerialization and rematerialization of securities for the quarter ended September 30, 2026, in compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.
Manipal Health Enterprises Ltd
28 Sep 2026 12:00 AM
Manipal Health Enterprises will restrict securities trading ahead of September 2026 results,
Manipal Health Enterprises Limited will close its trading window for securities dealings from October 1, 2026, and will reopen it 48 hours after the announcement of its financial results for the quarter and half-year ended September 30, 2026, in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.
Manipal Health Enterprises Ltd
21 Aug 2026 12:00 AM
Manipal Health Enterprises Ltd consolidated sales up 7.23% on year in Q2FY2026, net profit saw a strong growth of 30.50%,
Manipal Health Enterprises Ltd share price declined by 2.73% to Rs 724.25. The Company`s net profit surged by 30.50% to Rs 243.43 crore, while revenue from operations improved marginally 7.23% to Rs 3090.63 crore in Q2FY26 over Q1FY26.
The market capitalization of Hospital industry group stocks on BSE stood at Rs 5.23 lakh crore, easing 7.46%. It has eased by 1.61% over last one week and spiked sharply by 25.80% in last one month while the market capitalization of Manipal Health Enterprises Ltd has remained flat
Profit before tax (PBT) of Manipal Health Enterprises Ltd stood at Rs 315.18 crore in Q2 FY26, slipping 8.43% year-on-year, and surging by 29.23% quarter-on-quarter. EBITDA came in at Rs 662 crore, rallying 23.03% YoY and gaining 0.97% sequentially.
Total expenses saw a slight increase of 6.96% to Rs 2541.27 crore in Q2FY26 over Q2FY25. During the quarter, employee benefits expense was at Rs 462.01 crore, jumping 18.03% YoY.
For the TTM ended FY26, revenue from operations surged 25.40% to Rs 10335.75 crore, while net profit contracted by 15.26% to Rs 916.59 crore, compared to previous TTM. EBITDA soared by 217771% to Rs 2426.47 crore, and PBT slipped by 5.17% to Rs 1178.1 crore compared to previous TTM.
The company`s consolidated net cash flow from operating activities stood at Rs 2078.4 crore in FY26, as against Rs 1569.83 crore in FY25.
Subscribe for our
newsletter
newsletter
HSL Mobile App